Shuttle Pharmaceuticals Inc

Company Profile

Shuttle Pharmaceuticals Inc had its IPO on 2022-08-31 under the ticker symbol SHPH.

The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. Shuttle Pharmaceuticals Inc has a staff strength of 7 employees.

Stock update

Shares of Shuttle Pharmaceuticals Inc opened at $0.68 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.68 - $0.75, and closed at $0.7.

This is a 0% increase from the previous day's closing price.

A total volume of 46,083 shares were traded at the close of the day’s session.

In the last one week, shares of Shuttle Pharmaceuticals Inc have slipped by -9.56%.

Shuttle Pharmaceuticals Inc's Key Ratios

Shuttle Pharmaceuticals Inc has a market cap of $12.18 million, indicating a price to book ratio of 4.7319 and a price to sales ratio of 0.

In the last 12-months Shuttle Pharmaceuticals Inc’s revenue was $0 with a gross profit of $0 and an EBITDA of $-4566624. The EBITDA ratio measures Shuttle Pharmaceuticals Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Shuttle Pharmaceuticals Inc’s operating margin was 0% while its return on assets stood at -63.44% with a return of equity of -212.06%.

In Q2, Shuttle Pharmaceuticals Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Shuttle Pharmaceuticals Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-0.31 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Shuttle Pharmaceuticals Inc’s profitability.

Shuttle Pharmaceuticals Inc stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of -18.5648. Its price to sales ratio in the trailing 12-months stood at 0.

Shuttle Pharmaceuticals Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$8.84 million

Total Liabilities

$493682.00

Operating Cash Flow

$0

Capital Expenditure

$0

Dividend Payout Ratio

0%

Shuttle Pharmaceuticals Inc ended 2024 with $8.84 million in total assets and $0 in total liabilities. Its intangible assets were valued at $8.84 million while shareholder equity stood at $6.94 million.

Shuttle Pharmaceuticals Inc ended 2024 with $0 in deferred long-term liabilities, $493682.00 in other current liabilities, 155.00 in common stock, $-12054357.00 in retained earnings and $0 in goodwill. Its cash balance stood at $5.45 million and cash and short-term investments were $8.35 million. The company’s total short-term debt was $329,430 while long-term debt stood at $122309.00.

Shuttle Pharmaceuticals Inc’s total current assets stands at $8.44 million while long-term investments were $0 and short-term investments were $2.90 million. Its net receivables were $6950.00 compared to accounts payable of $88741.00 and inventory worth $78949.00.

In 2024, Shuttle Pharmaceuticals Inc's operating cash flow was $0 while its capital expenditure stood at $0.

Comparatively, Shuttle Pharmaceuticals Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$0.7

52-Week High

$41.864

52-Week Low

$0.519

Analyst Target Price

$

Shuttle Pharmaceuticals Inc stock is currently trading at $0.7 per share. It touched a 52-week high of $41.864 and a 52-week low of $41.864. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $0.87 and 200-day moving average was $1.44 The short ratio stood at 0.99 indicating a short percent outstanding of 0%.

Around 5681.6% of the company’s stock are held by insiders while 29.2% are held by institutions.